- Home
- PRVA vs CLVT Comparison
PRVA vs CLVT Comparison
Compare PRVA & CLVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- CLVT
- Stock Information
- Founded
- PRVA 2007
- CLVT 2016
- Country
- PRVA United States
- CLVT United Kingdom
- Employees
- PRVA N/A
- CLVT N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- CLVT EDP Services
- Sector
- PRVA Technology
- CLVT Technology
- Exchange
- PRVA Nasdaq
- CLVT Nasdaq
- Market Cap
- PRVA 2.6B
- CLVT 2.8B
- IPO Year
- PRVA 2021
- CLVT N/A
- Fundamental
- Price
- PRVA $21.78
- CLVT $4.34
- Analyst Decision
- PRVA Strong Buy
- CLVT Hold
- Analyst Count
- PRVA 13
- CLVT 4
- Target Price
- PRVA $28.23
- CLVT $4.83
- AVG Volume (30 Days)
- PRVA 964.6K
- CLVT 4.5M
- Earning Date
- PRVA 08-07-2025
- CLVT 07-30-2025
- Dividend Yield
- PRVA N/A
- CLVT N/A
- EPS Growth
- PRVA N/A
- CLVT N/A
- EPS
- PRVA 0.11
- CLVT N/A
- Revenue
- PRVA $1,900,071,000.00
- CLVT $2,500,300,000.00
- Revenue This Year
- PRVA $95.64
- CLVT N/A
- Revenue Next Year
- PRVA $10.27
- CLVT N/A
- P/E Ratio
- PRVA $198.29
- CLVT N/A
- Revenue Growth
- PRVA 12.05
- CLVT N/A
- 52 Week Low
- PRVA $16.47
- CLVT $3.04
- 52 Week High
- PRVA $26.09
- CLVT $7.15
- Technical
- Relative Strength Index (RSI)
- PRVA 59.26
- CLVT 62.18
- Support Level
- PRVA $20.92
- CLVT $4.41
- Resistance Level
- PRVA $22.09
- CLVT $4.56
- Average True Range (ATR)
- PRVA 0.61
- CLVT 0.13
- MACD
- PRVA 0.14
- CLVT 0.04
- Stochastic Oscillator
- PRVA 81.86
- CLVT 88.33
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.